Lantheus has completed its acquisition of Evergreen Theragnostics, Inc. Please see the press release to learn more.

CDMO Products & Pipeline Therapeutic Areas

Menu

About us Facilities News Careers

CDMO Products & Pipeline Therapeutic Areas About us Facilities News Careers

menu

Close

CDMO Products & Pipeline Therapeutic Areas

Menu

About us Facilities News Careers

CDMO Products & Pipeline Therapeutic Areas About us Facilities News Careers

menu

Improving the options for cancer patients through theragnostic radiopharmaceuticals